1,000
Participants
Start Date
February 28, 2019
Primary Completion Date
July 5, 2028
Study Completion Date
July 5, 2028
Atezolizumab
Atezolizumab will be administered as a monotherapy or atezolizumab with other agent(s) as per parent protocol. Dosing regimen will continue in accordance with the parent study or at equivalent dose (if applicable) and at the same schedule as the parent study, or switch to a fixed atezolizumab dose of 1200 mg every 3 weeks (Q3W).
Bevacizumab
Bevacizumab will be administered as directed per the parent study.
Alectinib
Alectinib will be administered as directed per the parent study.
Cobimetinib
Cobimetinib will be administered as directed per the parent study.
Vemurafenib
Vemurafenib will be administered as directed per the parent study.
FAP IL2V
FAP IL2V will be administered as directed per the parent study.
Venetoclax
Venetoclax will be administered as directed per the parent study.
Enzalutamide
Enzalutamide will be administered as directed per the parent study.
Pembrolizumab
Pembrolizumab will be administered as directed per the parent study.
Sunitinib
Sunitinib will be administered as directed per the parent study.
Niraparib
Niraparib will be administered as directed per the parent study.
Cabozantinib
Cabozantinib will be administered as directed per the parent study.
Pemetrexed
Pemetrexed will be administered as directed per the parent study.
Paclitaxel
Paclitaxel will be administered as directed per the parent study.
Emactuzumab
Emactuzumab will be administered as directed per the parent study.
Rucaparib
Rucaparib will be administered as directed per the parent study.
Institut Jules Bordet, Brussels
UZ Brussel, Brussels
Orszagos Onkologiai Intezet, Budapest
St Vincent'S Hospital, Darlinghurst
Rigshospitalet, København Ø
UZ Leuven, Leuven
Multiprofile Hospital for Active Treatment Central Onco Hospital OOD, Plovdiv
Samsung Medical Center, Seoul
Faculty of Med. Siriraj Hosp., Bangkok
Anticancer Hospital Ag. Savas, Athens
hopital de la Timone, Marseille
St. Luke's Cancer Care Associates, Bethlehem
Metropolitan Hospital, Piraeus
Istituto Nazionale dei Tumori, Milan
HOPA MVZ GmbH, Hamburg
Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lübeck
Clinica Universidad de Navarra-Madrid, Madrid
Hospital Universitario Madrid Sanchinarro, Madrid
Carolina BioOncology Institute, PLCC, Huntersville
Advent Health Orlando, Maitland
Lungenfachklinik Immenhausen, Immenhausen
National Cancer Institute MOH of Ukraine, Kiev
Regional Municipal Institution Sumy Regional Clinical Oncology Dispensary, Sumy
Volyn Regional Oncology Dispensary, Lutsk
Kliniken Essen-Mitte, Essen
Universitaetsklinikum Muenster, Münster
CHU Angers, Angers
ME Kryviy Rih Oncology Dispensary of Dnipropetrovs?k Regional Council, Kryvyi Rih
Phylasis Clinicas Research S de RL de CV, Toluca
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez, Lille
Communal Non profit Enterprise Regional Center of Oncology, Kharkiv
Universitätsklinikum Heidelberg, Heidelberg
Universitaets-Hautklinik Tuebingen, Tübingen
Universitaettsklinikum Tübingen, Tübingen
Universitätsklinik Tübingen, Tübingen
University of Texas Health Sciences Center in San Antonio, San Antonio
Universitätsklinikum Freiburg, Freiburg im Breisgau
University of Colorado Cancer Center, Aurora
Asklepios-Fachklinik Muenchen-Gauting, Gauting
Universitätsklinikum Ulm, Ulm
Krankenhaus Barmherzige Bruder Regensburg, Regensburg
Institut Gustave Roussy, Villejuif
Russian Oncology Research Center n.a. N.N. Blokhin, Moscow
P.A. Herzen Oncological Inst., Moscow
Arkhangelsk Regional Clinical Oncology Dispensary, Arkhangelsk
Centrul de Oncologie Sfantul Nectarie, Craiova
Centrul de Oncologie Oncohelp, Timișoara
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca, Cluj-Napoca
Institutul Regional de Oncologie Iasi, Iași
Pontificia Universidad Catolica de Chile, Santiago
Yale University School Of Medicine, Trumbull
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Hospital Araujo Jorge, Goiânia
Hospital das Clinicas - UFRGS, Porto Alegre
Queen Mary Hospital, Hong Kong
Szegedi Tudományegyetem, Szeged
Seoul National University College of Medicine, Liver Research Institute, Seoul
Masaryk?v onkologický ústav, Brno
Centre Antoine Lacassagne, Nice
SRH Wald-Klinikum Gera, Gera
Laiko General Hospital Athen, Athens
Grupo Angeles, Guatemala City
Nagoya University Hospital, Aichi
National Hospital Organization Shikoku Cancer Center, Ehime
National Hospital Organization Kyushu Medical Center, Fukuoka
Kyushu University Hospital, Fukuoka
Hokkaido University Hospital, Hokkaido
University of Tsukuba Hospital, Ibaraki
Kanazawa University Hospital, Ishikawa
Sendai Kousei Hospital, Miyagi
Niigata University Medical & Dental Hospital, Niigata
Osaka Habikino Medical Center, Osaka
NHO Kinki-Chuo Chest Medical Center, Sakaishi
Uniwersytecki Szpital Kliniczny w Poznaniu, Pozna?
Centrum Onkologii im. Prof. F. Lukaszczyka w Bydgoszczy, Bydgoszcz
Szpital Specjalistyczny Podkarpacki O?rodek Onkologiczny, Brzozów
Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, Otwock
Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy, Otwock
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna
Narodowy Instytut Onkologii im. Marii Sk?odowskiej-Curie - Pa?stwowy Instytut Badawczy, Warsaw
Dolnoslaskie Centrum Onkologii, Wroc?aw
University Hospital Bratislava, Bratislava
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Uni Ulsan Collegemedicine, Seoul
Hospital Universitario Quiron Dexeus, Barcelona
Hoffmann-La Roche
INDUSTRY